Skip to Main Content

Paper Details

ALK Amplification and Rearrangements Are Recurrent Targetable Events in Congenital and Adult Glioblastoma.
Clin Cancer Res
5
2023
ALK, ALK fusions, ALK mutations, ALK protein, ALK-fused GBM, Anaplastic lymphoma kinase, Congenital and Adult Glioblastoma, DCTN1, ERK1, GBMs, LRRFIP1, PRKD3, STAT3, ceritinib, congenital, congenital GBM, congenital/infant GBMs, glioblastomas, gliomas, infant, infant gliomas, infant, pediatric, and adult GBMs, mice, mouse, patient, patient cells
Author NameAffiliation
Shakti H RamkissoonDana-Farber Cancer Institute
Lori A RamkissoonDana-Farber Cancer Institute
Robert T JonesDana-Farber Cancer Institute
Kristine PeltonDana-Farber Cancer Institute
Michael Y TolstorukovDana-Farber Cancer Institute
Michael Y TolstorukovDana-Farber Cancer Institute
Liliana C Goumnerova
Mark W Kieran
Mark W Kieran
Rishi R LullaHasbro Children's Hospital
Rishi R LullaHasbro Children's Hospital
Azra H LigonDana-Farber Cancer Institute
Azra H Ligon
Azra H LigonBrigham and Women's Hospital
Azra H LigonHarvard Medical School
Adrian M DubucDana-Farber Cancer Institute
Adrian M DubucBrigham and Women's Hospital
M??lanie Pag??sInstitute Curie
M??lanie Pag??sINSERM U, SIREDO Pediatric Oncology Center, Institute Curie
M??lanie Pag??sInstitute Curie
M??lanie Pag??sINSERM U, SIREDO Pediatric Oncology Center, Institute Curie
Pascale VarletSainte-Anne Hospital
Pascale VarletSainte-Anne Hospital
Patrick Y WenDana-Farber Cancer Institute
Patrick Y WenHarvard Medical School
Sanda AlexandrescuDana-Farber Cancer Institute
Sanda Alexandrescu
Ralf KittlerUniversity of Texas Southwestern Medical Center
Pratiti BandopadhayayDana-Farber Cancer Institute
Pratiti BandopadhayayHarvard Medical School
Pratiti BandopadhayayBroad Institute of Harvard and MIT
Pratiti Bandopadhayay
Rameen BeroukhimDana-Farber Cancer Institute
Rameen BeroukhimHarvard Medical School
Rameen BeroukhimBroad Institute of Harvard and MIT
Rameen BeroukhimBrigham and Women's Hospital
Keith L LigonDana-Farber Cancer Institute
Keith L LigonHarvard Medical School
Keith L LigonBroad Institute of Harvard and MIT
Keith L LigonBrigham and Women's Hospital
Keith L Ligon
Keith L LigonDana-Farber Cancer Institute, Center for Patient-Derived Models (CPDM)
  • 1 - 42

Datasets

Release 1.2